Cetera Advisor Networks LLC Abb Vie Inc. Transaction History

Cetera Advisor Networks LLC

$0
Q1 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $730,057 - $831,832	-4,568 Reduced 1.59%	282,993 $51.5 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $47,334 - $53,309	-344 Reduced 0.12%	287,561 $44.6 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $521,535 - $603,753	3,904 Added 1.37%	287,905 $42.9 Million
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $163,782 - $203,816	-1,236 Reduced 0.43%	284,001 $38.3 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $1.45 Million - $1.67 Million	10,031 Added 3.64%	285,237 $45.5 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $6.33 Million - $7.59 Million	45,765 Added 19.95%	275,206 $44.5 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $4.16 Million - $4.78 Million	31,024 Added 15.64%	229,441 $30.8 Million
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $1.38 Million - $1.75 Million	10,007 Added 5.31%	198,417 $30.4 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $898,387 - $1.11 Million	6,807 Added 3.75%	188,410 $30.5 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $641,249 - $811,366	5,969 Added 3.4%	181,603 $24.6 Million
Q3 2021 Nov 16, 2021	BUY	$106.4 - $120.78 $1.34 Million - $1.52 Million	12,588 Added 7.72%	175,634 $18.9 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $8.56 Million - $9.54 Million	81,353 Added 99.58%	163,046 $18.4 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $695,128 - $765,252	6,795 Added 9.07%	81,693 $8.84 Million
Q4 2020 Feb 17, 2021	BUY	$80.49 - $108.67 $496,864 - $670,819	6,173 Added 8.98%	74,898 $8.03 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $107,988 - $126,743	1,257 Added 1.86%	68,725 $6.02 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $675,077 - $903,354	9,201 Added 15.79%	67,468 $6.62 Million
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $59,791 - $90,651	927 Added 1.62%	58,267 $4.44 Million
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $302,873 - $378,959	4,199 Added 7.9%	57,340 $5.08 Million
Q3 2019 Nov 06, 2019	BUY	$62.98 - $75.72 $2,267 - $2,725	36 Added 0.07%	53,141 $4.03 Million
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $276,531 - $353,471	4,209 Added 8.61%	53,105 $3.86 Million
Q1 2019 May 06, 2019	SELL	$77.14 - $90.79 $138,080 - $162,514	-1,790 Reduced 3.53%	48,896 $3.92 Million
Q4 2018 Feb 15, 2019	BUY	$77.85 - $96.01 $222,650 - $274,588	2,860 Added 5.98%	50,686 $4.66 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $887,321 - $986,423	9,980 Added 26.37%	47,826 $4.52 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $54,227 - $64,162	-604 Reduced 1.57%	37,846 $3.51 Million
Q1 2018 May 09, 2018	SELL	$92.01 - $123.21 $251,187 - $336,363	-2,730 Reduced 6.63%	38,450 $3.64 Million
Q4 2017 Feb 08, 2018	BUY	$89.56 - $98.21 $11,195 - $12,276	125 Added 0.3%	41,180 $3.99 Million
Q3 2017 Nov 16, 2017	SELL	$69.85 - $89.22 $113,436 - $144,893	-1,624 Reduced 3.81%	41,055 $3.65 Million
Q2 2017 Aug 14, 2017	BUY	N/A	42,679	42,679 $3.1 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.

Account